MoneyWorks4Me

The revenue zoomed 7.64% to Rs. 412.16 millions for the quarter ended September 2024 as compared to Rs. 382.89 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended September 2024 rise to 31.14% to Rs. 96.02  millions  compared to R. 73.22 millions in corresponding previous quarter.Operating profit surged to 132.79 millions from the corresponding previous quarter of 102.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 412.16 382.89 7.64 737.52 674.64 9.32 1419.66 1367.49 3.82
Other Income 18.53 10.96 69.07 32.59 21.33 52.79 46.67 51.23 -8.90
PBIDT 132.79 102.00 30.19 239.73 182.04 31.69 377.85 354.90 6.47
Interest 1.16 0.69 68.12 2.31 1.43 61.54 2.71 3.67 -26.16
PBDT 131.63 101.31 29.93 237.42 180.61 31.45 375.14 351.23 6.81
Depreciation 6.39 5.91 8.12 11.58 10.91 6.14 23.40 22.59 3.59
PBT 125.24 95.40 31.28 225.84 169.70 33.08 351.74 328.64 7.03
TAX 29.22 22.18 31.74 55.67 42.79 30.10 91.98 82.58 11.38
Deferred Tax -0.78 -3.48 -77.59 0.67 -2.89 -123.18 -5.21 -2.25 131.56
PAT 96.02 73.22 31.14 170.17 126.91 34.09 259.76 246.06 5.57
Equity 44.13 44.13 0.00 44.13 44.13 0.00 44.13 44.13 0.00
PBIDTM(%) 32.22 26.64 20.94 32.50 26.98 20.46 26.62 25.95 2.55
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..